CME stock: buy or sell?

CME stock price: $211.15 -0.38% At close on September 20th, 2019

Updated on:
September 20th, 2019


CME shares depreciated -0.38% to $211.15 today.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Should I buy CME stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, CME stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean CME will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is CME stock a buy?

Financial institutions and banks publish stock ratings everyday. At, we detected 15 ratings published for CME stock in the last 30 days.

Is CME a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-5UBS Groupn/aNeutral
2019-9-19Berenberg BankBuyHold
2019-8-9Deutsche Bankn/aBuy
2019-7-3Wells Fargo & Con/aMarket Perform
2019-7-3Wells Fargo & Con/aMarket Perform
2019-7-3UBS Groupn/aNeutral
2019-6-5UBS Groupn/aNeutral
2019-5-2UBS GroupNeutralNeutral
2019-3-22JPMorgan Chase & Co.n/aUnderweight
2019-3-15Deutsche BankBuyBuy
2019-2-15Sanford C. Bernsteinn/aOutperform
2019-2-15JPMorgan Chase & Co.NeutralUnderweight

CME stock analysis

Daily outlook

Shares of CME closed today at $211.15 and depreciated an unpleasant -0.38%.

CME closed today at $211.15 and depreciated an unpleasant -0.38%. Since SMA100d and SMA200d crossed up on July, CME price climbed $17.69 per share (9.14%). On May CME price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On Sep/6, CME hit new all time highs, pushing higher previous ATH of $224.10 recorded on Sep 5th. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

CME stock chart (daily)

Weekly outlook

After sliding a dreadful -8.03% in a week last week, CME closed this week at $211.15 and soared a nice 2.60%.

Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $224.15 resistance. Not so far away is the last price record CME marked early September. Early July, SMA20w and SMA40w crossed up triggering a rise of 9.14%. Early May CME price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

CME stock chart (weekly)

CME stock price history

CME stock went public on December 6th, 2002 with a price of $4.851. Since then, CME stock grew a 4,253.60%, with an average of 265.90% per year. If you had invested $1,000 in CME stock in 2002, it would worth $42,536.00 today.

1: Adjusted price after possible price splits or reverse-splits.

CME stock historical price chart

CME stock reached all-time highs on Sep 6th with a price of $224.15.

CME stock price target is $200.40

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' CME stock price predictions in the hope that they will be met as they may be wrong and not met. We detected 14 price targets for CME stock released in the last month:
CME stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-5UBS GroupRaises Target$191.00$214.0012%
2019-9-19Berenberg BankDowngrades$236.00$227.00-3.8%
2019-8-9Deutsche BankRaises Target$224.00$240.007.1%
2019-7-3Wells Fargo & CoReiterates$176.00$200.0013.6%
2019-7-3Wells Fargo & CoRaises Target$176.00$200.0013.6%
2019-7-3UBS GroupRaises Target$190.00$194.002.1%
2019-6-5UBS GroupRaises Target$175.00$190.008.6%
2019-5-23BarclaysRaises Target$191.00$197.003.1%
2019-5-2UBS GroupLowers Target$179.00$175.00-2.2%
2019-5-2CitigroupSet Price Targetn/a$202.00-
2019-3-26BarclaysLowers Target$210.00$193.00-8.1%
2019-3-22JPMorgan Chase & Co.Lowers Target$164.00$150.00-8.5%
2019-3-15Deutsche BankLowers Target$220.00$214.00-2.7%
2019-2-15Sanford C. BernsteinReiteratesn/a$210.00-
(in average)$194.30$200.403.0%
The price target for CME stock is $200.40, moving in a range between $240.00 and $150.00. In average, analysts' outlook on CME price target is positive, upgrading the target by a 3.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, CME was in line with the forecasts of the experts and reported an EPS of $1.77 per share. Unfortunately, reported EPS is not yet available in our database.
CME earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual sales report draw an astounding growth of 18.24% to $4,309.40 million dollars. Instead, its earnings margin (compared to sales) collapsed to 45.53%, that is $1,962.20 million.

CME annual Sales and Income evolution
2013$2,930 M-$977 M33.3%-
2014$3,113 M6.23%$1,127 M36.2%15.39%
2015$3,327 M6.89%$1,247 M37.5%10.64%
2016$3,595 M8.07%$1,534 M42.7%23.02%
2017$3,645 M1.38%$4,063 M111.5%164.87%
2018$4,309 M18.24%$1,962 M45.5%-51.71%

Quarterly financial results

CME posted $1,236.60 million in revenues for 2018-Q4, a 36.76% improvement compared to previous quarter. Reported quarter income marked $385.50 M with a profit margin of 31.17%. Profit margin plummed a -14.37% compared to previous quarter when profit margin was 45.54%. When comparing revenues to same quarter last year, CME sales marked an outstanding gain and climbed a 37.40%.
CME quarterly Sales and Income evolution
2017-Q2$925 M-$416 M45.0%-
2017-Q3$891 M-3.66%$309 M34.6%-25.78%
2017-Q4$900 M1.03%$2,939 M326.6%852.43%
2018-Q1$1,109 M23.22%$599 M54.0%-79.63%
2018-Q2$1,060 M-4.45%$566 M53.4%-5.46%
2018-Q3$904 M-14.67%$412 M45.5%-27.26%
2018-Q4$1,237 M36.76%$386 M31.2%-6.39%
2019-Q1$1,180 M-4.61%$497 M42.1%28.90%

CME ownership

When you are planning to invest in a company, it's worth to have a look its ownership structure.

CME shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 1.64% of all shares.

Bearish positions for CME stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to CME:

Market cap$75.6 B$13.0 B$0.0 M$52.4 B$12.9 B
Total shares358.1 M111.7 M0.0 M560.4 M37.8 M
Float shares349.0 M110.5 M0.0 M553.8 M36.4 M
  - Institutional holdings (%)87.9%83.2%0.0%0.0%106.0%
  - Insider holdings (%)1.6%0.9%0.0%93.2%2.6%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

CME summary

Friday, September 20th, 2019
Day range$209.78 - $212.89
Previous close$211.95
Session gain-0.38%
Average true range$5.27
50d mov avg$209.00
100d mov avg$199.89
200d mov avg$187.79
Daily patternlt02a
Weekly pattern lb02a

CME performance

To better understand CME performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare CME to Cboe Global Markets, Interactive Brokers, Intercontinental Exchange, MarketAxess, MSCI and Nasdaq:
CME 7.29%30.21%23.60%
CBOECboe Global Marke...9.51%22.48%9.78%
IBKRInteractive Broke...-2.46%3.84%-9.00%
ICEIntercontinental ...8.09%29.32%21.74%
MSCI -2.57%18.33%29.71%

CME competitors

One check before trading any stock is to review a list of its competitors, in this case for CME. We picked 6 companies as CME competitors as they are in the same industry or have similar market objectives.

Latest CME stock news